BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Biolato M, Paratore M, Di Gialleonardo L, Marrone G, Grieco A. Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence? World J Hepatol 2022; 14(4): 682-695 [PMID: 35646264 DOI: 10.4254/wjh.v14.i4.682]
URL: https://www.wjgnet.com/1948-9366/full/v14/i4/682.htm
Number Citing Articles
1
Jing Qian, Shun‐zhong Gu, Yong‐jin Yan. Determination of rivaroxaban in rat plasma by ultra‐high‐performance liquid chromatography–Q‐Orbitrap high‐resolution mass spectrometry and its application to a pharmacokinetic studyBiomedical Chromatography 2022; 36(12) doi: 10.1002/bmc.5491
2
Nicoletta Riva, Walter Ageno. How to manage splanchnic vein thrombosis in patients with liver diseaseHematology 2023; 2023(1): 281 doi: 10.1182/hematology.2023000481
3
Aitor Odriozola, Ángela Puente, Antonio Cuadrado, Coral Rivas, Ángela Anton, Francisco José González, Raúl Pellón, Emilio Fábrega, Javier Crespo, José Ignacio Fortea. Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive ReviewJournal of Clinical Medicine 2022; 11(21): 6435 doi: 10.3390/jcm11216435
4
Giovanni Monaco, Luca Bucherini, Bernardo Stefanini, Fabio Piscaglia, Francesco Giuseppe Foschi, Luca Ielasi. Direct oral anticoagulants for the treatment of splanchnic vein thrombosis: A state of artWorld Journal of Gastroenterology 2023; 29(33): 4962-4974 doi: 10.3748/wjg.v29.i33.4962
5
Xia Ren, Yuan Huang, LiPing Ying, JinBo Wang. Risk factors of venous thromboembolism for liver tumors: a systematic review and meta-analysisHPB 2024; 26(1): 1 doi: 10.1016/j.hpb.2023.09.008